ALBUQUERQUE, N.M. and TORONTO, Aug. 23, 2011 /PRNewswire/ —
VeraLight Inc., the first company to develop an optical skin
measurement for noninvasive diabetes screening, and Pear Healthcare
Solutions Inc., a leading provider of in-pharmacy health screening
and education services, today announced an agreement for the
distribution of the SCOUT DS device in pharmacies across
Canada.
“Since gaining our Health Canada License Approval and European
CE Mark, we have been thrilled with the level of interest in
distributing SCOUT DS outside of the United States,” said David Van
Avermaete, CEO of VeraLight. “After an extensive review, we
chose Pear as our partner to bring the SCOUT DS to Canadian
pharmacies based on its track record as a respected provider of
high quality testing services and education for consumers on behalf
of pharmacies, pharmaceutical and device companies.”
“We at Pear Healthcare Solutions are proud to have been selected
by VeraLight as its first distribution and education partner,” said
Mark Doyle, Vice President of Sales and Marketing for Pear. “I am
confident that by providing this technology to Canadian pharmacies,
we can make a positive difference in the healthcare system and in
people’s lives. The potential to identify people with
undiagnosed diabetes or prediabetes could reduce long-term
healthcare costs and improve the quality of lives for Canadians. We
will introduce the device with screening events in two pharmacies
in Ontario in August and expand across the country in the coming
months.” More information is available at http://www.pearhealthcare.com.
About SCOUT DS®
The SCOUT DS is the first noninvasive test that can replace
conventional blood-based diabetes screening. The easy to operate
SCOUT DS device needs no blood and does not require fasting. The
patient simply places a forearm on the portable table-top unit, and
a quantitative result is re
‘/>”/>
SOURCE
